Search

A leader must be confident and obedient to others. This situation, in order to see in the future and to provide for possible gaps or failures in the business functioning. We chose the most important actor of economic action: the CEO, manager or leader. He is the propeller for the entire activity and factor for decision-making. The methodology consists in using positivism, empiric research, inductive approach. We tried to highlight the importance of the co-relation between the needs of a company, firm, organization and the managerial/leading style and skills of the CEO. Also, mainly in the corporate sector and regarding the financial performances of the firm, the CEO-leader is more efficient than the CEO-manager. This fact, because the first one is mainly focused on the global image, on the growth of the company, on implementation and improvement of the strategies. On the other hand, the disruptions appeared on short time, or even suddenly, are better handled by the CEO-managers. [ABSTRACT FROM AUTHOR]

The increase in the prevalence of type 2 diabetes and the worldwide expansion of overweight and obesity are intrinsically linked. The percentage of diabetes attributable to weight gain amounts to more than 80% in many countries. This relationship is addressed in a Spanish Consensus Document from SEMI, SED, redGDPS, SEC, SEEDO, SEEN, SEMERGEN and SEMFYC published in 2015 and which gathers best available evidences. Based on the statements of this consensus document, we propose five recommendations for clinical practice to establish a diagnosis of precision and the most appropriate treatment for joint diabetes and obesity. These recommendations have been agreed by the SENDIMAD, SOMAMFYC, SEMG Madrid and RedGDPS Working Groups: 1. For every patient with diabetes and obesity, in addition to the calculation of the body mass index, the percentage of body fat and the approximation to the assessment of body composition should be evaluated throughout the whole process (both at the beginning and follow up). 2. The approximation to the degree and distribution of body fat requires the measurement and recording of the waist circumference of these patients. 3. The integrated assessment of the patient with type 2 diabetes-obesity requires the evaluation of the degree of physical activity and/or characterization of the sedentary condition. 4. The prescription of lifestyle changes should be incorporated into therapeutic education (individualized, flexible, autonomous and sustainable diet and physical activity plan. 5. The pharmacological approach in the treatment of type 2 diabetes-obesity implies the choice of anti-diabetic drugs that facilitate the loss of fat.